Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.14M Buy
48,195
+10,492
+28% +$2.23M 0.05% 352
2025
Q4
$8.63M Buy
37,703
+6,709
+22% +$1.47M 0.05% 342
2025
Q3
$6.11M Buy
30,994
+4,522
+17% +$900K 0.04% 374
2025
Q2
$5.22M Buy
26,472
+1,173
+5% +$227K 0.04% 360
2025
Q1
$5.2M Buy
25,299
+1,984
+9% +$433K 0.06% 288
2024
Q4
$5.47M Buy
23,315
+8,963
+62% +$2.2M 0.07% 261
2024
Q3
$3.99M Buy
14,352
+9,323
+185% +$2.47M 0.08% 243
2024
Q2
$1.26M Buy
+5,029
New +$1.27M 0.06% 291

Other funds holding DHR

&Partners's DHR Position: Q1 2026 in Review

&Partners increased its Danaher (DHR) stake by 28% in Q1 2026, buying an estimated $2.23M and bringing the position to 48,195 shares worth $9.14M. The position accounts for 0.05% of the portfolio, ranked #352.

&Partners first reported a position in DHR in Q2 2024 and has held it in 8 quarters since. 2,165 funds tracked by Wall St. Rank hold DHR as of Q1 2026.

  • &Partners held 48,195 shares of Danaher worth $9.14M as of Q1 2026.
  • &Partners bought 10,492 Danaher shares in Q1 2026, an estimated $2.23M.
  • Danaher made up 0.05% of &Partners's portfolio in Q1 2026, its #352 holding.
  • &Partners first reported a position in Danaher in Q2 2024 and has held it in 8 quarters since.
  • 2,165 funds tracked by Wall St. Rank held Danaher as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.